AC Immune SA

Filed a patent for "dihydropyrrolo[3,4c]-pyrazole derivatives and their use in diagnosis" on Thu, May 9, 2024

Filed a patent for "dihydropyrrolo[3,4-c]pyrazole derivatives and their use in diagnosis" on Thu, May 9, 2024

Filed a patent for "4h-imidazo[1,5-b]pyrazole derivatives for diagnosis" on Fri, May 10, 2024

Filed a patent for "vaccine therapy" on Thu, August 15, 2024

Filed a patent for "misfolded tdp-43 binding molecules" on Thu, October 26, 2023

Filed a patent for "novel compounds for diagnosis" on Thu, June 8, 2023

Filed a patent for "dihydrooxazole and thiourea derivatives modulating the nlrp3 inflammasome pathway" on Thu, August 10, 2023

Filed a patent for "immunogenic compounds" on Thu, September 14, 2023

Filed a patent for "humanized anti-tdp-43 binding molecules and uses thereof" on Thu, October 12, 2023

Filed a patent for "heterologous administration of tau vaccines" on Thu, August 17, 2023

Filed a patent for "bicyclic compounds for diagnosis and therapy" on Thu, February 15, 2024

Filed a patent for "novel compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates" on Thu, August 17, 2023

Filed a patent for "novel compounds" on Thu, December 7, 2023

Filed a patent for "method of safe administration of phosphorylated tau peptide vaccine" on Thu, November 30, 2023

Filed a patent for "antibody delivery" on Thu, March 28, 2024

Filed a patent for "novel compounds" on Thu, February 1, 2024

Filed a patent for "novel compounds" on Thu, March 28, 2024

Filed a patent for "novel compounds for the diagnosis of tdp-43 proteinopathies" on Tue, January 16, 2024

Filed a patent for "dose treatments of tauopathies" on Thu, April 20, 2023